Name | Multicaulisin |
---|---|
Synonyms |
6-[(1R,5S,6R)-6-(2,4-Dihydroxybenzoyl)-5-(2,4-dihydroxyphenyl)-3-(4-methyl-3-penten-1-yl)-2-cyclohexen-1-yl]-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one
4H-1-Benzopyran-4-one, 6-[(1R,5S,6R)-6-(2,4-dihydroxybenzoyl)-5-(2,4-dihydroxyphenyl)-3-(4-methyl-3-penten-1-yl)-2-cyclohexen-1-yl]-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy- |
Description | Multicaulisin, a new Diels-Alder type adduct from Morus multicaulis roots, potently effects against Staphylococcus aureus (MRSA) isolates. Multicaulisin is an antibacterial drug and has the potential for MRSA infections research[1][2]. |
---|---|
Related Catalog | |
In Vitro | Multicaulisin potently effects against MRSA isolates with minimal inhibitory concentrations (MICs)/ minimal bactericidal concentrations (MBCs) at 2-8/16-128 mg/L[1]. |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 972.4±65.0 °C at 760 mmHg |
Molecular Formula | C40H36O11 |
Molecular Weight | 692.707 |
Flash Point | 303.8±27.8 °C |
Exact Mass | 692.225769 |
LogP | 7.25 |
Vapour Pressure | 0.0±0.3 mmHg at 25°C |
Index of Refraction | 1.710 |